SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is surging following a blowout earnings report characterized by massive revenue growth and significantly raised full-year guidance, which has fueled intense bullish sentiment among community members. The stock is currently the center of a heated debate between retail investors celebrating the company's AI-driven execution and short-sellers who remain skeptical of the high valuation and aggressive rhetoric from CEO Alex Karp.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is at the center of intense market debate as investors brace for the company's first earnings report followed by a significant IPO share lock-up expiration. The community is sharply divided between bulls betting on a short squeeze fueled by massive short interest and bearish concerns regarding high cash burn and the potential for heavy selling pressure when a large volume of insider shares becomes available for trading.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently trending as investors debate whether the recent sharp decline represents a structural washout or a compelling value entry point for a sector rotation. Market participants are intensely focused on the conclusion of the company's accelerated share buyback program and are actively scrutinizing upcoming earnings for signs of a turnaround in procedure volumes.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae shares are trending as investors speculate on potential structural reforms and a possible exit from conservatorship under the current administration, with the community actively debating whether legislative progress or privatization plans will drive a major valuation shift. While some shareholders remain skeptical due to past delays and government involvement, many are closely monitoring policy developments and high-profile investor sentiment for signs of an imminent IPO or uplisting.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors closely track progress toward a Biologics License Application filing, with the community actively debating the company's manufacturing timelines, potential buyout prospects, and the clinical efficacy of its CAN-2409 immunotherapy. While some long-term holders highlight the company's RMAT designation and strong institutional backing, others are skeptical due to ongoing share dilution concerns and the timeline for final regulatory milestones.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is currently trending as investors weigh strong domestic steel demand and positive long-term growth catalysts against persistent concerns over the company's debt levels and recent share price volatility. Community sentiment remains polarized, with many participants debating the potential for a strategic partnership or buyout while others scrutinize executive leadership and the stock's recent technical performance.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is currently capturing market attention as investors monitor its progress in integrating electro-optic polymers into next-generation silicon photonics, with community members closely watching for potential partnership announcements or material supply deals involving industry leaders like Marvell or Broadcom. The discussion centers on the company's long-term commercialization timeline for high-volume production, while retail investors remain divided between frustration over the lack of recent catalysts and optimism regarding the potential of Perkinamine technology to resolve critical AI data center power and bandwidth bottlenecks.

Tema ETF Trust - Tema Space Innovators ETF

Tema Space Innovators ETF

Tema Space Innovators ETF (NASA) is trending as investors grapple with the recent SpaceX IPO, which holds a significant but complex weight in the fund through a lock-up period. While the community remains divided over the ETF's performance relative to the sector, active discussion centers on the potential for long-term growth in the space economy and whether to accumulate positions during current volatility.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Internet Computer (ICP) is attracting investor interest as the community highlights its pivot toward sovereign cloud infrastructure, on-chain AI integration, and recent institutional engagements like the UNDP Blockchain Advisory Group. While sentiment remains divided between those frustrated by historical price volatility and those bullish on the project's long-term utility, discussions currently focus on potential deflationary mechanisms and its ambition to compete with traditional cloud providers.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

Investors in MoonLake Immunotherapeutics are closely monitoring the upcoming IZAR-1 clinical trial data for sonelokimab, with community sentiment split between frustration over timing delays and bullish anticipation of a potential market re-rating. While discussions on message boards reflect skepticism regarding past trial performance and management transparency, many active participants are accumulating shares in expectation of best-in-class results that could catalyze a significant valuation shift.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
